Use of faricimab for refractory diabetic macular edema in real-world clinical practice: When anatomical success meets functional limits
Faricimab achieved effective retinal fluid control in both naïve and refractory diabetic macular edema, but visual recovery was associated with baseline retinal microstructural integrity, with DRIL and ELM/EZ disruption independently associated with poorer 12-month visual outcomes beyond conventional anatomical paramet...